174 related articles for article (PubMed ID: 38000729)
1. Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells.
Schwartz LS; Young KA; Stearns TM; Boyer N; Mujica KD; Trowbridge JJ
Exp Hematol; 2024 Feb; 130():104131. PubMed ID: 38000729
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M is a Master Regulator of an Inflammatory Network in
Schwartz LS; Young KA; Stearns TM; Boyer N; Mujica KD; Trowbridge JJ
bioRxiv; 2023 Jul; ():. PubMed ID: 37502912
[TBL] [Abstract][Full Text] [Related]
3. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21.
Zhang CR; Ostrander EL; Kukhar O; Mallaney C; Sun J; Haussler E; Celik H; Koh WK; King KY; Gontarz P; Challen GA
Blood Cancer Discov; 2022 May; 3(3):220-239. PubMed ID: 35394496
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.
Zioni N; Bercovich AA; Chapal-Ilani N; Bacharach T; Rappoport N; Solomon A; Avraham R; Kopitman E; Porat Z; Sacma M; Hartmut G; Scheller M; Muller-Tidow C; Lipka D; Shlush E; Minden M; Kaushansky N; Shlush LI
Nat Commun; 2023 Apr; 14(1):2070. PubMed ID: 37045808
[TBL] [Abstract][Full Text] [Related]
5. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
Hormaechea-Agulla D; Matatall KA; Le DT; Kain B; Long X; Kus P; Jaksik R; Challen GA; Kimmel M; King KY
Cell Stem Cell; 2021 Aug; 28(8):1428-1442.e6. PubMed ID: 33743191
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis.
Sato F; Miyaoka Y; Miyajima A; Tanaka M
PLoS One; 2014; 9(12):e116209. PubMed ID: 25551451
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.
Minehata K; Takeuchi M; Hirabayashi Y; Inoue T; Donovan PJ; Tanaka M; Miyajima A
Int J Hematol; 2006 Nov; 84(4):319-27. PubMed ID: 17118758
[TBL] [Abstract][Full Text] [Related]
9. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment.
Chen J; Matatall KA; Feng X; Hormaechea-Agulla D; Maharjan M; Young N; King KY
Exp Hematol; 2020 Nov; 91():39-45.e2. PubMed ID: 32961298
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
[TBL] [Abstract][Full Text] [Related]
11. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell pool.
Higo T; Suzuki Y; Sato M; Koya J; Mizuno H; Miyauchi M; Masamoto Y; Kataoka K; Sumitomo Y; Tsuruta-Kishino T; Sato T; Kurokawa M
Exp Hematol; 2022 May; 109():45-54. PubMed ID: 35245608
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stromal Cell Senescence Induced by
Mistry JJ; Young KA; Colom Díaz PA; Maestre IF; Levine RL; Trowbridge JJ
bioRxiv; 2024 Mar; ():. PubMed ID: 38585779
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines.
Yanai N; Obinata M
In Vitro Cell Dev Biol Anim; 2001; 37(10):698-704. PubMed ID: 11776976
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.
Torossian F; Guerton B; Anginot A; Alexander KA; Desterke C; Soave S; Tseng HW; Arouche N; Boutin L; Kulina I; Salga M; Jose B; Pettit AR; Clay D; Rochet N; Vlachos E; Genet G; Debaud C; Denormandie P; Genet F; Sims NA; Banzet S; Levesque JP; Lataillade JJ; Le Bousse-Kerdilès MC
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093266
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
17. Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.
Albiero M; Ciciliot S; Tedesco S; Menegazzo L; D'Anna M; Scattolini V; Cappellari R; Zuccolotto G; Rosato A; Cignarella A; Giorgio M; Avogaro A; Fadini GP
Diabetes; 2019 Jun; 68(6):1303-1314. PubMed ID: 30936144
[TBL] [Abstract][Full Text] [Related]
18. Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis.
SanMiguel JM; Eudy E; Loberg MA; Young KA; Mistry JJ; Mujica KD; Schwartz LS; Stearns TM; Challen GA; Trowbridge JJ
Cancer Discov; 2022 Dec; 12(12):2763-2773. PubMed ID: 36169447
[TBL] [Abstract][Full Text] [Related]
19. Role of Oncostatin M in hematopoiesis and liver development.
Miyajima A; Kinoshita T; Tanaka M; Kamiya A; Mukouyama Y; Hara T
Cytokine Growth Factor Rev; 2000 Sep; 11(3):177-83. PubMed ID: 10817961
[TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis in frequent whole blood donors.
Karpova D
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):299-304. PubMed ID: 38066913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
